SAVD
is a SARS-CoV-2 direct, lyophilized, rapid RT-PCR test with results within 30 minutes.
Latest NEWS
Confirmation report on the SARS-CoV-2 mutations and SAVD test diagnostic capability
Why SAVD?
CE IVD accreditation and being used commercially in the UK, Norway, Spain, Portugal, Czechia, Uganda, and Poland
No RNA purification or sample preparation required
Sensitivity 98%
Specificity 100%
Limit of detection 20 copies
per ml
- Rapid RT-PCR test (results within around 30 minutes)
- Direct test (no RNA isolation step needed)
- Target sequence - Orf1ab (single gene), works on current mutated strains
- Lyophilized reagents in 8-well strips
- VTM (Viral Transport Medium) included
- Delivered with virus inactivating buffer (verified by Public Health England, UK)
- Sample collection kits, pipettes and pipette tips included
- Customer service (help desk) included
- Based on GeneMe's patented enzymes
- CE IVD registered product (EU regulation)
SAVD Videos
SAVD – HOW TO PERFORM THE TEST
(DIRECT SAMPLES)
SAVD – HOW TO PERFORM THE TEST
(ISOLATED RNA SAMPLES)
About GeneMe
- Biotech company based in North Poland, operating in the field of genetic laboratory diagnostics and data analysis
- Inventor and manufcaturer of genetic tests as well as a diagnostic service provider in Poland
- Focused on reducing the time taken and accuracy of genetic analysis
- Patented technology procedure allows for the development of any other new genetic tests in 2–4 weeks if required
- Highly specialized team operating in the field of genetic diagnostics
Get in touch
GeneMe has distributors all over the world so please contact us via email biznes@geneme.eu
CONTACT
GeneMe Sp. z o.o.
ul. Kampinoska 25
80-180 Gdańsk
e-mail: biznes@geneme.eu
telephone: +48 517 169 126
availability: 9:00–17:00 CET/CEST
DOCUMENTS
Menu
All rights reserved. © 2021, GeneMe Sp. z o.o.
Design: Hajduk Studio